Cincinnati Children's Hospital Medical Center Pediatric Hematology/Oncology

Topics

• Hemoglobinopathies and Related Disorders 516
• Hematopoietic Stem Cell Transplantation 261
• Childhood Cancer Survivors' Quality of Life 219
• Autoimmune and Inflammatory Disorders Research 159
• Acute Lymphoblastic Leukemia research 115
• Glioma Diagnosis and Treatment 109
• Immunodeficiency and Autoimmune Disorders 102
• Sarcoma Diagnosis and Treatment 101
• Acute Myeloid Leukemia Research 93
• Complement system in diseases 67
• Vascular Malformations and Hemangiomas 67
• CAR-T cell therapy research 65

Most cited

1. Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101).

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 213 citations · David Dickens

2. GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomas.

   Nature · 2022 · 697 citations · Aaron Mochizuki

3. Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas.

   Nature · 2025 · 172 citations · Jennifer Kamens

4. The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia.

   Nature · 2023 · 458 citations · David Dickens

5. Proton FLASH Radiotherapy for the Treatment of Symptomatic Bone Metastases: The FAST-01 Nonrandomized Trial.

   JAMA oncology · 2023 · 283 citations · John Perentesis

6. Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome.

   Transplantation and cellular therapy · 2023 · 331 citations · Rebecca Marsh

7. Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology Commission.

   The Lancet. Haematology · 2023 · 134 citations · Russell Ware

8. Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.

   The New England journal of medicine · 2023 · 219 citations · Joseph Pressey